• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CSN1 通过上调细胞周期蛋白 A2 的表达促进肝癌细胞的增殖和迁移。

CSN1 facilitates proliferation and migration of hepatocellular carcinoma cells by upregulating cyclin A2 expression.

机构信息

Department of Hepatobiliary Surgery, Daping Hospital, Army Medical University, Chongqing 400042, P.R. China.

出版信息

Mol Med Rep. 2021 Jan;23(1). doi: 10.3892/mmr.2020.11684. Epub 2020 Nov 17.

DOI:10.3892/mmr.2020.11684
PMID:33200803
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7705997/
Abstract

Constitutive photomorphogenesis 9 signalosome subunit 1 (CSN1) plays an important role in the ubiquitin-proteasome pathway and regulates various cellular processes, such as the cell cycle and DNA repair. The CSN complex consists of eight subunits (CSN1 to CSN8) and regulates the tumorigenesis of a variety of tumor types. However, the exact role of CSN1 in hepatocellular carcinoma (HCC) remains unclear. The present study evaluated the expression and biological effects of CSN1 in HCC tissue samples and cell lines. CSN1 was significantly overexpressed in HCC tissue and cell lines, compared with their normal counterparts. In patients with HCC, elevated CSN1 levels correlated with tumor size, tumor metastasis and tumor stage. Loss‑of‑function assays indicated that CSN1 knockdown inhibited the proliferation and migration HCC cells. In addition, CSN1 promoted the expression of cyclin A2 in a ubiquitination‑independent manner. Lastly, xenograft experiments indicated that CSN1 promoted HCC tumor growth in vivo. The present study suggested that CSN1 inhibition could represent a potential approach for the prevention of HCC progression and metastasis.

摘要

组成型光形态建成 9 信号小体亚基 1(CSN1)在泛素-蛋白酶体途径中发挥重要作用,并调节各种细胞过程,如细胞周期和 DNA 修复。CSN 复合物由八个亚基(CSN1 至 CSN8)组成,调节多种肿瘤类型的肿瘤发生。然而,CSN1 在肝细胞癌(HCC)中的确切作用尚不清楚。本研究评估了 CSN1 在 HCC 组织样本和细胞系中的表达和生物学效应。与正常组织相比,CSN1 在 HCC 组织和细胞系中显著过表达。在 HCC 患者中,CSN1 水平升高与肿瘤大小、肿瘤转移和肿瘤分期相关。功能丧失实验表明,CSN1 敲低抑制 HCC 细胞的增殖和迁移。此外,CSN1 以非泛素化依赖的方式促进细胞周期蛋白 A2 的表达。最后,异种移植实验表明 CSN1 促进 HCC 肿瘤在体内生长。本研究表明,CSN1 抑制可能代表预防 HCC 进展和转移的一种潜在方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9214/7705997/4c167aa9e63a/mmr-23-01-11684-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9214/7705997/502230ec6971/mmr-23-01-11684-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9214/7705997/73f0447c8d61/mmr-23-01-11684-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9214/7705997/bc390d44b2dd/mmr-23-01-11684-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9214/7705997/4c167aa9e63a/mmr-23-01-11684-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9214/7705997/502230ec6971/mmr-23-01-11684-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9214/7705997/73f0447c8d61/mmr-23-01-11684-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9214/7705997/bc390d44b2dd/mmr-23-01-11684-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9214/7705997/4c167aa9e63a/mmr-23-01-11684-g03.jpg

相似文献

1
CSN1 facilitates proliferation and migration of hepatocellular carcinoma cells by upregulating cyclin A2 expression.CSN1 通过上调细胞周期蛋白 A2 的表达促进肝癌细胞的增殖和迁移。
Mol Med Rep. 2021 Jan;23(1). doi: 10.3892/mmr.2020.11684. Epub 2020 Nov 17.
2
MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.微小 RNA-301b-3p 通过抑制遗迹样家族成员 4 促进人肝细胞癌的肿瘤生长。
J Cell Mol Med. 2019 Aug;23(8):5037-5047. doi: 10.1111/jcmm.14361. Epub 2019 Jun 17.
3
Long non-coding RNAs HERH-1 and HERH-4 facilitate cyclin A2 expression and accelerate cell cycle progression in advanced hepatocellular carcinoma.长非编码 RNA HERH-1 和 HERH-4 促进细胞周期蛋白 A2 的表达并加速晚期肝细胞癌的细胞周期进程。
BMC Cancer. 2021 Aug 26;21(1):957. doi: 10.1186/s12885-021-08714-7.
4
ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway.ERCC6L 通过激活 PI3K/AKT 和 NF-κB 信号通路促进肝癌的进展。
BMC Cancer. 2020 Sep 5;20(1):853. doi: 10.1186/s12885-020-07367-2.
5
Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression.长链非编码RNA MKLN1‑AS通过充当miR‑654‑3p的分子海绵发挥作用,从而促进肝癌衍生生长因子的表达,进而加剧肝细胞癌的进展。
Int J Mol Med. 2020 Nov;46(5):1743-1754. doi: 10.3892/ijmm.2020.4722. Epub 2020 Sep 9.
6
miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators.miR-214/199a/199a*簇水平通过干扰细胞周期调节因子预测肝细胞癌患者的不良生存。
Oncotarget. 2016 Jan 5;7(1):929-45. doi: 10.18632/oncotarget.6137.
7
CSN5 Promotes Hepatocellular Carcinoma Progression by SCARA5 Inhibition Through Suppressing β-Catenin Ubiquitination.CSN5 通过抑制 SCARA5 来抑制 β-连环蛋白泛素化从而促进肝癌进展。
Dig Dis Sci. 2018 Jan;63(1):155-165. doi: 10.1007/s10620-017-4855-9. Epub 2017 Nov 30.
8
Long non-coding RNA GAS6-AS1 acts as a ceRNA for microRNA-585, thereby increasing expression and facilitating hepatocellular carcinoma oncogenicity.长链非编码RNA GAS6-AS1作为微小RNA-585的竞争性内源RNA,从而增加其表达并促进肝细胞癌的致癌性。
Cell Cycle. 2020 Apr;19(7):742-757. doi: 10.1080/15384101.2020.1729323. Epub 2020 Feb 23.
9
Overexpression of CSN6 promotes the epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.CSN6 的过表达促进了肝癌中的上皮-间充质转化,并预测了不良的预后。
Clin Res Hepatol Gastroenterol. 2020 Jun;44(3):340-348. doi: 10.1016/j.clinre.2019.07.012. Epub 2019 Aug 14.
10
Immature colon carcinoma transcript-1 promotes cell growth of hepatocellular carcinoma via facilitating cell cycle progression and apoptosis resistance.不成熟结肠癌细胞转录因子 1 通过促进细胞周期进程和抗细胞凋亡促进肝癌细胞生长。
Oncol Rep. 2017 Dec;38(6):3489-3496. doi: 10.3892/or.2017.6046. Epub 2017 Oct 19.

引用本文的文献

1
Differential roles of cyclin-CDK1 complexes in cell migration and invasion.细胞周期蛋白-CDK1复合物在细胞迁移和侵袭中的不同作用。
J Cell Sci. 2025 Jul 1;138(13). doi: 10.1242/jcs.263697. Epub 2025 Jul 14.
2
DNA copy number profiles and systems biology connect chromatin remodeling and DNA repair in high-risk neuroblastoma.DNA拷贝数图谱与系统生物学揭示高危神经母细胞瘤中染色质重塑与DNA修复的联系
Genet Mol Biol. 2024 Sep 2;47(3):e20240007. doi: 10.1590/1678-4685-GMB-2024-0007. eCollection 2024.
3
COP9 signalosome complex is a prognostic biomarker and corresponds with immune infiltration in hepatocellular carcinoma.

本文引用的文献

1
Tmub1 Suppresses Hepatocellular Carcinoma by Promoting the Ubiquitination of ΔNp63 Isoforms.Tmub1通过促进ΔNp63亚型的泛素化来抑制肝细胞癌。
Mol Ther Oncolytics. 2020 Jun 4;18:126-136. doi: 10.1016/j.omto.2020.06.005. eCollection 2020 Sep 25.
2
CSN6 promotes tumorigenesis of gastric cancer by ubiquitin-independent proteasomal degradation of p16.CSN6通过对p16进行非泛素依赖性蛋白酶体降解来促进胃癌的肿瘤发生。
Cancer Biol Med. 2019 Aug;16(3):514-529. doi: 10.20892/j.issn.2095-3941.2018.0410.
3
Overexpression of CSN6 promotes the epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
COP9信号体复合物是一种预后生物标志物,与肝细胞癌中的免疫浸润相关。
Aging (Albany NY). 2024 Mar 11;16(6):5264-5287. doi: 10.18632/aging.205646.
4
Integrated proteome and phosphoproteome analysis of gastric adenocarcinoma reveals molecular signatures capable of stratifying patient outcome.胃腺癌的整合蛋白质组和磷酸化蛋白质组分析揭示了能够对患者预后进行分层的分子特征。
Mol Oncol. 2023 Feb;17(2):261-283. doi: 10.1002/1878-0261.13361. Epub 2022 Dec 29.
5
Screening of Hub Genes in Hepatocellular Carcinoma Based on Network Analysis and Machine Learning.基于网络分析和机器学习的肝细胞癌关键基因筛选。
Comput Math Methods Med. 2022 Nov 28;2022:7300788. doi: 10.1155/2022/7300788. eCollection 2022.
6
Molecular Regulation of Yak Preadipocyte Differentiation and Proliferation by and ceRNA Regulatory Network Analysis.牦牛前体脂肪细胞分化和增殖的分子调控及 ceRNA 调控网络分析。
Cells. 2022 Aug 1;11(15):2366. doi: 10.3390/cells11152366.
7
Mammaglobin 1 mediates progression of trastuzumab-resistant breast cancer cells through regulation of cyclins and NF-κB.Mammaglobin 1 通过调节细胞周期蛋白和 NF-κB 促进曲妥珠单抗耐药乳腺癌细胞的进展。
FEBS Open Bio. 2022 Oct;12(10):1797-1813. doi: 10.1002/2211-5463.13468. Epub 2022 Aug 9.
8
Targeting the COP9 signalosome for cancer therapy.靶向COP9信号体用于癌症治疗。
Cancer Biol Med. 2022 Mar 21;19(5):573-90. doi: 10.20892/j.issn.2095-3941.2021.0605.
9
miR‑374c‑5p regulates PTTG1 and inhibits cell growth and metastasis in hepatocellular carcinoma by regulating epithelial‑mesenchymal transition.miR-374c-5p 通过调控上皮-间充质转化抑制 PTTG1 表达进而抑制肝癌细胞的生长和转移。
Mol Med Rep. 2022 Apr;25(4). doi: 10.3892/mmr.2022.12664. Epub 2022 Mar 2.
10
promotes the development of hepatocellular carcinoma by mediating DNA replication in the cell cycle.促进肝癌的发展,通过介导细胞周期中的 DNA 复制。
Exp Biol Med (Maywood). 2022 Mar;247(5):395-408. doi: 10.1177/15353702211049149. Epub 2021 Nov 7.
CSN6 的过表达促进了肝癌中的上皮-间充质转化,并预测了不良的预后。
Clin Res Hepatol Gastroenterol. 2020 Jun;44(3):340-348. doi: 10.1016/j.clinre.2019.07.012. Epub 2019 Aug 14.
4
Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets.肝细胞癌:信号转导、表观遗传和免疫靶点治疗进展。
World J Gastroenterol. 2019 Jul 7;25(25):3136-3150. doi: 10.3748/wjg.v25.i25.3136.
5
CSN6 expression is associated with pancreatic cancer progression and predicts poor prognosis.CSN6 表达与胰腺癌的进展相关,并预测预后不良。
Cancer Biol Ther. 2019;20(9):1290-1299. doi: 10.1080/15384047.2019.1632143. Epub 2019 Jul 16.
6
Role of Radiotherapy in the Treatment of Hepatocellular Carcinoma.放射疗法在肝细胞癌治疗中的作用
J Clin Transl Hepatol. 2019 Jun 28;7(2):183-190. doi: 10.14218/JCTH.2018.00060. Epub 2019 May 27.
7
Hepatocellular carcinoma treatment: hurdles, advances and prospects.肝细胞癌治疗:障碍、进展与前景
Hepat Oncol. 2018 Sep 28;5(2):HEP08. doi: 10.2217/hep-2018-0002. eCollection 2018 Apr.
8
CSN6 Promotes the Migration and Invasion of Cervical Cancer Cells by Inhibiting Autophagic Degradation of Cathepsin L.CSN6 通过抑制组织蛋白酶 L 的自噬降解促进宫颈癌的迁移和侵袭。
Int J Biol Sci. 2019 May 12;15(6):1310-1324. doi: 10.7150/ijbs.32987. eCollection 2019.
9
The Emerging Role of CSN6 in Biological Behavior and Cancer Progress.CSN6 在生物学行为和癌症进展中的新兴作用。
Anticancer Agents Med Chem. 2019;19(10):1198-1204. doi: 10.2174/1871520619666190408142131.
10
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.